Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lightwood syndrome revisited with a novel mutation in CYP24 and vitamin D supplement recommendations.

The Journal of pediatrics - 1 Oct 2013

Castanet Mireille, Mallet Eric, Kottler Marie-Laure

Abstract excerpt

A novel mutation in CYP24A1 provides insight into idiopathic infantile hypercalcemia. In this report of 3 brothers, in twins supplemented with vitamin D (1900 IU/d), only the twin homozygous for CYP24A1 exhibited idiopathic infantile hypercalcemia. A subsequently affected younger brother given vi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Dietary Supplements
Share to Hypercalcemia
Share to Infant, Newborn, Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Metabolism, Inborn Errors

Share to Parathyroid Hormone

Share to Steroid Hydroxylases

Share to Vitamin D

Share to Vitamin D3 24-Hydroxylase

Source

Identifiers

PMID: 23768816
DOI: 10.1016/j.jpeds.2013.04.056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23768816-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lightwood syndrome revisited with a novel mutation in CYP24 and vitamin D supplement recommendations.PMID 23768816Read ↗

Infantile hypercalcemia type 1 (HCINF1): a rare disease resulting in nephrolithiasis and nephrocalcinosis caused by mutations in the vitamin D catabolic enzyme, CYP24A1.Semantic proximity Read ↗

Mutations in CYP24A1 and idiopathic infantile hypercalcemia.Semantic proximity Read ↗

Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutationSemantic proximity Read ↗

Clinical and Molecular Spectrum of Infantile Hypercalcemia Type I: Insights Into CYP24A1 Variants.Semantic proximity Read ↗

Clinical heterogeneity and therapeutic options for idiopathic infantile hypercalcemia caused by CYP24A1 pathogenic variant.Semantic proximity Read ↗

Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake.Semantic proximity Read ↗

Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutationSemantic proximity Read ↗

CYP24A1 Mutation in a Girl Infant with Idiopathic Infantile Hypercalcemia.Semantic proximity Read ↗

Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review.Semantic proximity Read ↗

Genetic Diseases of Vitamin D Metabolizing Enzymes.Semantic proximity Read ↗

[New Mutation of CYP24A1 in a Case of Idiopathic Infantile Hypercalcemia Diagnosed in Adulthood].Semantic proximity Read ↗

Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity: molecular study of 11 historical IIH cases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.